Iron metabolism and related genetic diseases: A cleared land, keeping mysteries

Journal of Hepatology

Volumn 64, Issue 2, 2016, Pages 505-515

  Brissot, Pierre ^a   Loréal, Olivier ^a  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

Author keywords

Ceruloplasmin; Erythroferrone; Ferritin; Ferroportin; Haemochromatosis; Haemochromatosis; Liver.Iron; Hemojuvelin; Hepcidin; Iron; Liver; Non transferrin bound iron; Transferrin; Transferrin receptor

Indexed keywords

IRON;

ANTIBODY SPECIFICITY; GENETICS; HUMAN; INBORN ERROR OF METABOLISM; IRON METABOLISM DISORDER; LIVER; METABOLISM;

HUMANS; IRON; IRON METABOLISM DISORDERS; LIVER; METABOLISM, INBORN ERRORS; ORGAN SPECIFICITY;

EID: 84954306618     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2015.11.009     Document Type: Review

References (120)

1. D. Meynard, J.L. Babitt, and H.Y. Lin The liver: conductor of systemic iron balance Blood 123 2014 168 176
2. N.C. Andrews, and P.J. Schmidt Iron homeostasis Annu Rev Physiol 69 2007 69 85
3. D.J. Lane, A.M. Merlot, M.L. Huang, D.H. Bae, P.J. Jansson, S. Sahni, and et al. Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease Biochim Biophys Acta 1853 2015 1130 1144
4. P. Brissot, T. Cavey, M.B. Troadec, M. Ropert, and O. Loréal Métabolisme du fer EMC Endocrinol Métabol 2015 1 11
5. D. Chiabrando, F. Vinchi, V. Fiorito, S. Mercurio, and E. Tolosano Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes Front Pharmacol 5 2014 61
6. A. Lawen, and D.J. Lane Mammalian iron homeostasis in health and disease: uptake, storage, transport, and molecular mechanisms of action Antioxid Redox Signal 18 2013 2473 2507
7. L. Davidsson Approaches to improve iron bioavailability from complementary foods J Nutr 133 2003 1560S 1562S
8. T.R. Halfdanarson, M.R. Litzow, and J.A. Murray Hematologic manifestations of celiac disease Blood 109 2007 412 421
9. C. Hershko, G. Graham, G.W. Bates, and E.A. Rachmilewitz Non-specific serum iron in thalassaemia: an abnormal serum iron fraction of potential toxicity Br J Haematol 40 1978 255 263
10. P. Brissot, T.L. Wright, W.L. Ma, and R.A. Weisiger Efficient clearance of non-transferrin-bound iron by rat liver. Implications for hepatic iron loading in iron overload states J Clin Invest 76 1985 1463 1470
11. C.M. Craven, J. Alexander, M. Eldridge, J.P. Kushner, S. Bernstein, and J. Kaplan Tissue distribution and clearance kinetics of non-transferrin-bound iron in the hypotransferrinemic mouse: a rodent model for hemochromatosis Proc Natl Acad Sci U S A 84 1987 3457 3461
12. J.P. Liuzzi, F. Aydemir, H. Nam, M.D. Knutson, and R.J. Cousins Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells Proc Natl Acad Sci U S A 103 2006 13612 13617
13. S. Jenkitkasemwong, C.Y. Wang, R. Coffey, W. Zhang, A. Chan, T. Biel, and et al. SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis Cell Metab 22 2015 138 150
14. R.C. Hider Nature of nontransferrin-bound iron Eur J Clin Invest 32 2002 50 54
15. P. Brissot, M. Ropert, C. Le Lan, and O. Loreal Non-transferrin bound iron: a key role in iron overload and iron toxicity Biochim Biophys Acta 1820 2012 403 410
16. B.P. Esposito, W. Breuer, P. Sirankapracha, P. Pootrakul, C. Hershko, and Z.I. Cabantchik Labile plasma iron in iron overload: redox activity and susceptibility to chelation Blood 102 2003 2670 2677
17. Z.I. Cabantchik, W. Breuer, G. Zanninelli, and P. Cianciulli LPI-labile plasma iron in iron overload Best Pract Res Clin Haematol 18 2005 277 287
18. C. Le Lan, O. Loreal, T. Cohen, M. Ropert, H. Glickstein, F. Laine, and et al. Redox active plasma iron in C282Y/C282Y hemochromatosis Blood 105 2005 4527 4531
19. Z.I. Cabantchik Labile iron in cells and body fluids: physiology, pathology, and pharmacology Front Pharmacol 5 2014 45
20. A.T. McKie, D. Barrow, G.O. Latunde-Dada, A. Rolfs, G. Sager, E. Mudaly, and et al. An iron-regulated ferric reductase associated with the absorption of dietary iron Science 291 2001 1755 1759
21. R.S. Ohgami, D.R. Campagna, A. McDonald, and M.D. Fleming The Steap proteins are metalloreductases Blood 108 2006 1388 1394
22. C.K. Mukhopadhyay, Z.K. Attieh, and P.L. Fox Role of ceruloplasmin in cellular iron uptake Science 279 1998 714 717
23. C.D. Vulpe, Y.M. Kuo, T.L. Murphy, L. Cowley, C. Askwith, N. Libina, and et al. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse Nat Genet 21 1999 195 199
24. P. Arosio, R. Ingrassia, and P. Cavadini Ferritins: a family of molecules for iron storage, antioxidation and more Biochim Biophys Acta 1790 2009 589 599
25. D.J. Lane, and D.R. Richardson The active role of vitamin C in mammalian iron metabolism: much more than just enhanced iron absorption! Free Radic Biol Med 75 2014 69 83
26. K. Jomova, and M. Valko Advances in metal-induced oxidative stress and human disease Toxicology 283 2011 65 87
27. P. Brissot, Y. Deugnier, D. Guyader, G. Zanninelli, O. Loreal, R. Moirand, and et al. Iron overload and the biliary route Adv Exp Med Biol 356 1994 277 283
28. P. Brissot, E. Bardou-Jacquet, A.M. Jouanolle, and O. Loreal Iron disorders of genetic origin: a changing world Trends Mol Med 17 2011 707 713
29. E. Tolosano Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis Haematologica 100 2015 565 566
30. S. Fishbane, A. Mathew, and N.D. Vaziri Iron toxicity: relevance for dialysis patients Nephrol Dial Transplant 29 2014 255 259
31. J.B. Porter, and M. Garbowski The pathophysiology of transfusional iron overload Hematol Oncol Clin North Am 28 2014 683 701 vi
32. R.R. Crichton Iron metabolism: from molecular mechanisms to clinical consequences 2009 Wiley edits
33. C. Pigeon, G. Ilyin, B. Courselaud, P. Leroyer, B. Turlin, P. Brissot, and et al. A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload J Biol Chem 276 2001 7811 7819
34. G. Nicolas, M. Bennoun, I. Devaux, C. Beaumont, B. Grandchamp, A. Kahn, and et al. Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice Proc Natl Acad Sci U S A 98 2001 8780 8785
35. O. Loreal, T. Cavey, E. Bardou-Jacquet, P. Guggenbuhl, M. Ropert, and P. Brissot Iron, hepcidin, and the metal connection Front Pharmacol 5 2014 128
36. T. Ganz Systemic iron homeostasis Physiol Rev 93 2013 1721 1741
37. N. Zhao, A.S. Zhang, and C.A. Enns Iron regulation by hepcidin J Clin Invest 123 2013 2337 2343
38. M.V. Verga Falzacappa, G. Casanovas, M.W. Hentze, and M.U. Muckenthaler A bone morphogenetic protein (BMP)-responsive element in the hepcidin promoter controls HFE2-mediated hepatic hepcidin expression and its response to IL-6 in cultured cells J Mol Med (Berl) 86 2008 531 540
39. G. Ramey, J.C. Deschemin, and S. Vaulont Cross-talk between the mitogen activated protein kinase and bone morphogenetic protein/hemojuvelin pathways is required for the induction of hepcidin by holotransferrin in primary mouse hepatocytes Haematologica 94 2009 765 772
40. M.W. Hentze, M.U. Muckenthaler, B. Galy, and C. Camaschella Two to tango: regulation of Mammalian iron metabolism Cell 142 2010 24 38
41. X.G. Wu, Y. Wang, Q. Wu, W.H. Cheng, W. Liu, Y. Zhao, and et al. HFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression Blood 124 2014 1335 1343
42. E. Corradini, D. Meynard, Q. Wu, S. Chen, P. Ventura, A. Pietrangelo, and et al. Serum and liver iron differently regulate the bone morphogenetic protein 6 (BMP6)-SMAD signaling pathway in mice Hepatology 54 2011 273 284
43. E. Ramos, L. Kautz, R. Rodriguez, M. Hansen, V. Gabayan, Y. Ginzburg, and et al. Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice Hepatology 53 2011 1333 1341
44. A.S. Zhang, S.A. Anderson, J. Wang, F. Yang, K. DeMaster, R. Ahmed, and et al. Suppression of hepatic hepcidin expression in response to acute iron deprivation is associated with an increase of matriptase-2 protein Blood 117 2011 1687 1699
45. A.T. McKie, P. Marciani, A. Rolfs, K. Brennan, K. Wehr, D. Barrow, and et al. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation Mol Cell 5 2000 299 309
46. I. De Domenico, D.M. Ward, E. Nemeth, M.B. Vaughn, G. Musci, T. Ganz, and et al. The molecular basis of ferroportin-linked hemochromatosis Proc Natl Acad Sci U S A 102 2005 8955 8960
47. C. Brasse-Lagnel, Z. Karim, P. Letteron, S. Bekri, A. Bado, and C. Beaumont Intestinal DMT1 cotransporter is down-regulated by hepcidin via proteasome internalization and degradation Gastroenterology 140 2011 e1261
48. E. Nemeth, S. Rivera, V. Gabayan, C. Keller, S. Taudorf, B.K. Pedersen, and et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin J Clin Invest 113 2004 1271 1276
49. A.E. Armitage, L.A. Eddowes, U. Gileadi, S. Cole, N. Spottiswoode, T.A. Selvakumar, and et al. Hepcidin regulation by innate immune and infectious stimuli Blood 118 2011 4129 4139
50. C. Besson-Fournier, C. Latour, L. Kautz, J. Bertrand, T. Ganz, M.P. Roth, and et al. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling Blood 120 2012 431 439
51. L. Kautz, G. Jung, E.V. Valore, S. Rivella, E. Nemeth, and T. Ganz Identification of erythroferrone as an erythroid regulator of iron metabolism Nat Genet 46 2014 678 684
52. L. Kautz, and E. Nemeth Molecular liaisons between erythropoiesis and iron metabolism Blood 124 2014 479 482
53. L. Detivaud, E. Nemeth, K. Boudjema, B. Turlin, M.B. Troadec, P. Leroyer, and et al. Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function Blood 106 2005 746 748
54. J.S. Maras, R. Maiwall, H.C. Harsha, S. Das, M.S. Hussain, C. Kumar, and et al. Dysregulated iron homeostasis is strongly associated with multiorgan failure and early mortality in acute-on-chronic liver failure Hepatology 61 2015 1306 1320
55. D.L. Zhang, M.C. Ghosh, and T.A. Rouault The physiological functions of iron regulatory proteins in iron homeostasis - an update Front Pharmacol 5 2014 124
56. N. Wilkinson, and K. Pantopoulos The IRP/IRE system in vivo: insights from mouse models Front Pharmacol 5 2014 176
57. M. Shayeghi, G.O. Latunde-Dada, J.S. Oakhill, A.H. Laftah, K. Takeuchi, N. Halliday, and et al. Identification of an intestinal heme transporter Cell 122 2005 789 801
58. A. Qiu, M. Jansen, A. Sakaris, S.H. Min, S. Chattopadhyay, E. Tsai, and et al. Identification of an intestinal folate transporter and the molecular basis for hereditary folate malabsorption Cell 127 2006 917 928
59. R.W. Evans, R. Rafique, A. Zarea, C. Rapisarda, R. Cammack, P.J. Evans, and et al. Nature of non-transferrin-bound iron: studies on iron citrate complexes and thalassemic sera J Biol Inorg Chem 13 2008 57 74
60. D.R. Richardson, D.J. Lane, E.M. Becker, M.L. Huang, M. Whitnall, Y. Suryo Rahmanto, and et al. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol Proc Natl Acad Sci U S A 107 2010 10775 10782
61. H. Shi, K.Z. Bencze, T.L. Stemmler, and C.C. Philpott A cytosolic iron chaperone that delivers iron to ferritin Science 320 2008 1207 1210
62. S. Leidgens, K.Z. Bullough, H. Shi, F. Li, M. Shakoury-Elizeh, T. Yabe, and et al. Each member of the poly-r(C)-binding protein 1 (PCBP) family exhibits iron chaperone activity toward ferritin J Biol Chem 288 2013 17791 17802
63. K. Gkouvatsos, G. Papanikolaou, and K. Pantopoulos Regulation of iron transport and the role of transferrin Biochim Biophys Acta 1820 2012 188 202
64. G. Porto, and M. De Sousa Iron overload and immunity World J Gastroenterol 13 2007 4707 4715
65. L.A. Cohen, L. Gutierrez, A. Weiss, Y. Leichtmann-Bardoogo, D.L. Zhang, D.R. Crooks, and et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway Blood 116 2010 1574 1584
66. P. Brissot, E. Bardou-Jacquet, A.M. Jouanolle, and O. Loreal Iron disorders of genetic origin: a changing world Trends Mol Med 17 2011 707 713
67. E. Bardou-Jacquet, Z. Ben Ali, M.P. Beaumont-Epinette, O. Loreal, A.M. Jouanolle, and P. Brissot Non-HFE hemochromatosis: pathophysiological and diagnostic aspects Clin Res Hepatol Gastroenterol 2013
68. H. Drakesmith, L.M. Schimanski, E. Ormerod, A.T. Merryweather-Clarke, V. Viprakasit, J.P. Edwards, and et al. Resistance to hepcidin is conferred by hemochromatosis-associated mutations of ferroportin Blood 106 2005 1092 1097
69. R.L. Sham, P.D. Phatak, C. West, P. Lee, C. Andrews, and E. Beutler Autosomal dominant hereditary hemochromatosis associated with a novel ferroportin mutation and unique clinical features Blood Cells Mol Dis 34 2005 157 161
70. R.L. Sham, P.D. Phatak, E. Nemeth, and T. Ganz Hereditary hemochromatosis due to resistance to hepcidin: high hepcidin concentrations in a family with C326S ferroportin mutation Blood 114 2009 493 494
71. A. Fernandes, G.C. Preza, Y. Phung, I. De Domenico, J. Kaplan, T. Ganz, and et al. The molecular basis of hepcidin-resistant hereditary hemochromatosis Blood 114 2009 437 443
72. A. Pietrangelo Genetics, Genetic Testing and Management of Hemochromatosis: 15 years since hepcidin Gastroenterology 2015
73. E. Bardou-Jacquet, J. Philip, R. Lorho, M. Ropert, M. Latournerie, P. Houssel-Debry, D. Guyader, and et al. Liver transplantation normalizes serum hepcidin level and cures iron metabolism alterations in HFE hemochromatosis Hepatology 2013
74. Y. Gandon, D. Olivie, D. Guyader, C. Aube, F. Oberti, V. Sebille, and et al. Non-invasive assessment of hepatic iron stores by MRI Lancet 363 2004 357 362
75. T.G. St Pierre, P.R. Clark, W. Chua-anusorn, A.J. Fleming, G.P. Jeffrey, J.K. Olynyk, and et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance Blood 105 2005 855 861
76. J.C. Wood Impact of iron assessment by MRI Hematology Am Soc Hematol Educ Program 2011 2011 443 450
77. Y. Deugnier, and B. Turlin Pathology of hepatic iron overload Semin Liver Dis 31 2011 260 271
78. HAS French recommendations for management of HFE hemochromatosis 2005 Haute Autorité de Santé www.has-sante.fr
79. P. Brissot, S. Ball, D. Rofail, H. Cannon, and V.W. Jin Hereditary hemochromatosis: patient experiences of the disease and phlebotomy treatment Transfusion 51 2011 1331 1338
80. G. Porto, P. Brissot, D.W. Swinkels, H. Zoller, O. Kamarainen, S. Patton, I. Alonso, and et al. EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH) Eur J Hum Genet 2015
81. K.J. Allen, L.C. Gurrin, C.C. Constantine, N.J. Osborne, M.B. Delatycki, A.J. Nicoll, and et al. Iron-overload-related disease in HFE hereditary hemochromatosis N Engl J Med 358 2008 221 230
82. L.M. Fletcher, and L.W. Powell Hemochromatosis and alcoholic liver disease Alcohol 30 2003 131 136
83. R. Desgrippes, F. Laine, J. Morcet, M. Perrin, G. Manet, C. Jezequel, and et al. Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production Hepatology 57 2013 1784 1792
84. M.L. Island, A.M. Jouanolle, A. Mosser, Y. Deugnier, V. David, P. Brissot, and et al. A new mutation in the hepcidin promoter impairs its BMP response and contributes to a severe phenotype in HFE related hemochromatosis Haematologica 94 2009 720 724
85. L. Valenti, A.L. Fracanzani, R. Rametta, M. Fraquelli, G. Soverini, S. Pelusi, and et al. Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis J Hepatol 57 2012 1319 1325
86. C.E. McLaren, M.J. Emond, V.N. Subramaniam, P.D. Phatak, J.C. Barton, P.C. Adams, and et al. Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload Hepatology 62 2015 429 439
87. M. de Tayrac, M.P. Roth, A.M. Jouanolle, H. Coppin, G. le Gac, A. Piperno, and et al. Genome-wide association study identifies TF as a significant modifier gene of iron metabolism in HFE hemochromatosis J Hepatol 62 2015 664 672
88. J. Milet, V. Dehais, C. Bourgain, A.M. Jouanolle, A. Mosser, M. Perrin, and et al. Common variants in the BMP2, BMP4, and HJV genes of the hepcidin regulation pathway modulate HFE hemochromatosis penetrance Am J Hum Genet 81 2007 799 807
89. E. Fung, and E. Nemeth Manipulation of the hepcidin pathway for therapeutic purposes Haematologica 98 2013 1667 1676
90. O.T. Njajou, N. Vaessen, M. Joosse, B. Berghuis, J.W. van Dongen, M.H. Breuning, and et al. A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis Nat Genet 28 2001 213 214
91. G. Montosi, A. Donovan, A. Totaro, C. Garuti, E. Pignatti, S. Cassanelli, and et al. Autosomal-dominant hemochromatosis is associated with a mutation in the ferroportin (SLC11A3) gene J Clin Invest 108 2001 619 623
92. A. Pietrangelo The ferroportin disease Blood Cells Mol Dis 32 2004 131 138
93. H. Miyajima Aceruloplasminemia Neuropathology 35 2015 83 90
94. S. Kono Aceruloplasminemia: an update Int Rev Neurobiol 110 2013 125 151
95. A. Finkenstedt, E. Wolf, E. Hofner, B.I. Gasser, S. Bosch, R. Bakry, and et al. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation J Hepatol 53 2010 1101 1107
96. A. Hattori, N. Tomosugi, Y. Tatsumi, A. Suzuki, K. Hayashi, Y. Katano, and et al. Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis Blood Cells Mol Dis 48 2012 179 182
97. M. Tai, N. Matsuhashi, O. Ichii, T. Suzuki, Y. Ejiri, S. Kono, and et al. Case of presymptomatic aceruloplasminemia treated with deferasirox Hepatol Res 44 2014 1253 1258
98. M. Rusticeanu, V. Zimmer, L. Schleithoff, K. Wonney, J. Viera, A. Zimmer, and et al. Novel ceruloplasmin mutation causing aceruloplasminemia with hepatic iron overload and diabetes without neurological symptoms Clin Genet 85 2014 300 301
99. O. Loreal, B. Turlin, C. Pigeon, A. Moisan, M. Ropert, P. Morice, and et al. Aceruloplasminemia: new clinical, pathophysiological and therapeutic insights J Hepatol 36 2002 851 856
100. I. De Domenico, D.M. Ward, M.C. di Patti, S.Y. Jeong, S. David, G. Musci, and et al. Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI-ceruloplasmin EMBO J 26 2007 2823 2831
101. Y. Kaneko, H. Miyajima, A. Piperno, N. Tomosugi, H. Hayashi, N. Morotomi, and et al. Measurement of serum hepcidin-25 levels as a potential test for diagnosing hemochromatosis and related disorders J Gastroenterol 45 2010 1163 1171
102. S. Kono, K. Yoshida, N. Tomosugi, T. Terada, Y. Hamaya, S. Kanaoka, and et al. Biological effects of mutant ceruloplasmin on hepcidin-mediated internalization of ferroportin Biochim Biophys Acta 1802 2010 968 975
103. P. Guo, R. Cui, Y.Z. Chang, W.S. Wu, Z.M. Qian, K. Yoshida, and et al. Hepcidin, an antimicrobial peptide is downregulated in ceruloplasmin-deficient mice Peptides 30 2009 262 266
104. D. Aslan, K. Crain, and E. Beutler A new case of human atransferrinemia with a previously undescribed mutation in the transferrin gene Acta Haematol 118 2007 244 247
105. A. Iolascon, C. Camaschella, D. Pospisilova, C. Piscopo, G. Tchernia, and C. Beaumont Natural history of recessive inheritance of DMT1 mutations J Pediatr 152 2008 136 139
106. E. Bardou-Jacquet, M.L. Island, A.M. Jouanolle, L. Detivaud, N. Fatih, M. Ropert, and et al. A novel N491S mutation in the human SLC11A2 gene impairs protein trafficking and in association with the G212V mutation leads to microcytic anemia and liver iron overload Blood Cells Mol Dis 47 2011 243 248
107. S. Ducamp, C. Kannengiesser, M. Touati, L. Garcon, A. Guerci-Bresler, J.F. Guichard, and et al. Sideroblastic anemia: molecular analysis of the ALAS2 gene in a series of 29 probands and functional studies of 10 missense mutations Hum Mutat 32 2011 590 597
108. D.L. Guernsey, H. Jiang, D.R. Campagna, S.C. Evans, M. Ferguson, M.D. Kellogg, and et al. Mutations in mitochondrial carrier family gene SLC25A38 cause nonsyndromic autosomal recessive congenital sideroblastic anemia Nat Genet 41 2009 651 653
109. S. Bekri, G. Kispal, H. Lange, E. Fitzsimons, J. Tolmie, R. Lill, and et al. Human ABC7 transporter: gene structure and mutation causing X-linked sideroblastic anemia with ataxia with disruption of cytosolic iron-sulfur protein maturation Blood 96 2000 3256 3264
110. C. Camaschella, A. Campanella, L. De Falco, L. Boschetto, R. Merlini, L. Silvestri, and et al. The human counterpart of zebrafish shiraz shows sideroblastic-like microcytic anemia and iron overload Blood 110 2007 1353 1358
111. S. Besur, W. Hou, P. Schmeltzer, and H.L. Bonkovsky Clinically important features of porphyrin and heme metabolism and the porphyrias Metabolites 4 2014 977 1006
112. K.E. Finberg, M.M. Heeney, D.R. Campagna, Y. Aydinok, H.A. Pearson, K.R. Hartman, and et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) Nat Genet 40 2008 569 571
113. M.M. Heeney, and K.E. Finberg Iron-refractory iron deficiency anemia (IRIDA) Hematol Oncol Clin North Am 28 2014 637 652 v
114. L. De Falco, L. Silvestri, C. Kannengiesser, E. Moran, C. Oudin, M. Rausa, and et al. Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies Hum Mutat 35 2014 1321 1329
115. E. Poggiali, F. Andreozzi, I. Nava, D. Consonni, G. Graziadei, and M.D. Cappellini The role of TMPRSS6 polymorphisms in iron deficiency anemia partially responsive to oral iron treatment Am J Hematol 90 2015 306 309
116. D. Girelli, R. Corrocher, L. Bisceglia, O. Olivieri, L. De Franceschi, L. Zelante, and et al. Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation") Blood 86 1995 4050 4053
117. D. Yin, V. Kulhalli, and A.P. Walker Raised serum ferritin concentration in hereditary hyperferritinemia cataract syndrome is not a marker for iron overload Hepatology 59 2014 1204 1206
118. O. Bowes, K. Baxter, T. Elsey, M. Snead, and T. Cox Hereditary hyperferritinaemia cataract syndrome Lancet 383 2014 1520
119. C. Kannengiesser, A.M. Jouanolle, G. Hetet, A. Mosser, F. Muzeau, D. Henry, and et al. A new missense mutation in the L ferritin coding sequence associated with elevated levels of glycosylated ferritin in serum and absence of iron overload Haematologica 94 2009 335 339
120. A. Martelli, and H. Puccio Dysregulation of cellular iron metabolism in Friedreich ataxia: from primary iron-sulfur cluster deficit to mitochondrial iron accumulation Front Pharmacol 5 2014 130